LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

Penumbra Inc

Gesloten

SectorGezondheidszorg

297.02 2.91

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

295.12

Max

299.41

Belangrijke statistieken

By Trading Economics

Inkomsten

5.5M

39M

Verkoop

8.6M

324M

K/W

Sectorgemiddelde

276.636

54.379

EPS

0.83

Winstmarge

12.101

Werknemers

4,500

EBITDA

131K

49M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+6.28% upside

Dividenden

By Dow Jones

Volgende Winsten

29 jul 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

734M

11B

Vorige openingsprijs

294.11

Vorige sluitingsprijs

297.02

Nieuwssentiment

By Acuity

50%

50%

170 / 382 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Penumbra Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 mei 2025, 23:48 UTC

Winsten
Acquisities, Fusies, Overnames

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11 mei 2025, 23:46 UTC

Marktinformatie

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11 mei 2025, 23:45 UTC

Marktinformatie

Oil Rises Amid Improved Market Mood -- Market Talk

11 mei 2025, 23:38 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Aristocrat Has Significant Firepower for M&A -- Market Talk

11 mei 2025, 23:36 UTC

Marktinformatie

Global Markets Uncertain About US-China Trade News -- Market Talk

11 mei 2025, 23:35 UTC

Marktinformatie

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11 mei 2025, 23:33 UTC

Winsten
Acquisities, Fusies, Overnames

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11 mei 2025, 23:32 UTC

Top Nieuws

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11 mei 2025, 22:44 UTC

Marktinformatie

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11 mei 2025, 22:33 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11 mei 2025, 20:19 UTC

Top Nieuws

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11 mei 2025, 16:00 UTC

Top Nieuws

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11 mei 2025, 11:00 UTC

Top Nieuws

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11 mei 2025, 08:00 UTC

Top Nieuws

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11 mei 2025, 01:00 UTC

Top Nieuws

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11 mei 2025, 01:00 UTC

Top Nieuws

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10 mei 2025, 21:54 UTC

Top Nieuws

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10 mei 2025, 17:12 UTC

Top Nieuws

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10 mei 2025, 15:41 UTC

Top Nieuws

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10 mei 2025, 12:00 UTC

Top Nieuws

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10 mei 2025, 09:30 UTC

Top Nieuws

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10 mei 2025, 08:20 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

10 mei 2025, 03:52 UTC

Top Nieuws

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9 mei 2025, 23:51 UTC

Acquisities, Fusies, Overnames

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9 mei 2025, 22:06 UTC

Marktinformatie

Arm Holdings Remains a Strong Growth Story -- Market Talk

9 mei 2025, 21:37 UTC

Top Nieuws

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9 mei 2025, 21:10 UTC

Top Nieuws

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9 mei 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

9 mei 2025, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

9 mei 2025, 20:42 UTC

Top Nieuws

Stocks Get a Break From Trade Chaos -- WSJ

Peer Vergelijking

Prijswijziging

Penumbra Inc Prognose

Koersdoel

By TipRanks

6.28% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 316 USD  6.28%

Hoogste 340 USD

Laagste 260 USD

Gebaseerd op 16 Wall Street-analisten die 12-maands prijsdoelen bieden voor Penumbra Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

16 ratings

13

Buy

3

Hold

0

Sell

Technische score

By Trading Central

288.28 / 292.9394Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Weak Bullish Evidence

Sentiment

By Acuity

170 / 382 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.